GeoVax Labs, Inc. $GOVX is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases using its MVA-VLP vaccine platform. The company focuses on the development of vaccines against Human Immunodeficiency Virus (HIV), Zika virus, and hemorrhagic fever viruses. GeoVax Labs was founded by Robinson Harriet Latham and Hildebrand Donald G on September 9, 2006 and is headquartered in Smyrna, GA.